Multimorbidity in Pediatric Dermatology: Clinical Case

Background. Nowadays, dermatoses with mixed clinical picture and resistant to classical management become more common. The presence of various genetic disorders typical for most chronic dermatoses may indicate possible combination of several nosologies.

Clinical Case Description. The article presents the clinical case of multimorbid condition in 10 years old patient who has nucleotide variants in CARD14 and EXPH5 genes. Mutations in CARD14 gene are typical for patients with type 2 psoriasis and pityriasis rubra pilaris (autosomal dominant type), while mutations in EXPH5 gene are typical for patients with non-specific epidermolysis bullosa (autosomal recessive type). Mutation in the TGM1 gene that is described in patients with congenital ichthyosis (autosomal recessive type), pathogenic mutations in KRT74 gene typical for ectodermal dysplasia, hypotrichosis and uncombable hair syndrome, and mutations in the KRT86 gene typical for monilethrix were also revealed. Medical history taking and histological examination as well as clinical data evaluating are crucial for correct diagnosis. They allow to understand the absence of the such manifestations in relatives and reveal various pathological processes in the epidermis. Molecular genetic testing with new generation sequencing (NGS) helps to finally establish the diagnosis and determine the further tactics for patient management.

Conclusion. Multidisciplinary approach and use of high-technology methods of examination and treatment (such as molecular genetic testing and biological therapy) are required for final diagnosis in severe forms of chronic dermatosis resistant to treatment and for decision on correct tactics for the further management of such patients.

1. Fortin M., Bravo G., Hudon C., et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3(3): 223–228. doi: 10.1370/afm.272.

2. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68. doi: 10.1038/nrg2918.

3. Panteleeva GA, Suzdal’tseva IV, Goncharenko TS. Clinical examples of rare combinations of dermatoses. Russian Journal of Clinical Dermatology and Venerology = Klinicheskaya dermatologiya i venerologiya. 2011;(4):21–25. (In Russ).

4. Ryzhkova OP, Kardymon OL, Prohorchuk EB. Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2). Medical Genetics. 2019;18(2):3–23. (In Russ). doi: 10.25557/2073-7998.2019.02.3-23.

5. Lazebnik L.B. Polimorbidnost’ i starenie. Novosti meditsiny i farmatsii. 2007; (1(205)). (In Russ).

6. Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2016; 14(3):CD006560. doi: 10.1002/14651858.CD006560.pub3.

7. Glynn LG, Jose MV, Pamela H, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516–523. doi: 10.1093/fampra/cmr013.

8. Sambamoorthi U, Tan X, Deb A. Multiple chronic conditions and healthcare costs amongadults. Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):823–832. doi: 10.1586/14737167.2015.1091730.

9. Ren Z, Hsu DY, Brieva J, et al. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A. Br J Dermatol. 2017;176(1):87–99. doi: 10.1111/bjd.14821.

10. Santolini M, Barabasi AL. Predicting perturbation patterns from the topology of biological networks. Proc Natl Acad Sci USA. 2018;115(27):E6375–E6383. doi: 10.1073/pnas.1720589115.

11. Kitsak M, Sharma A, Menche J, et al. Tissue Specificity of Human Disease Module. Sci Rep. 2016;6:35241. doi: 10.1038/srep35241.

12. Lage K, Hansen NT, Karlberg EO, et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA. 2008;105(52): 20870–20875. doi: 10.1073/pnas.0810772105.

13. Barshir R, Shwartz O, Smoly IY, Yeger-Lotem E. Comparative analysis of human tissue interactomes reveals factors leading to tissue-specific manifestation of hereditary diseases. PLoS Comput Biol. 2014;10(6):e1003632. doi: 10.1371/journal.pcbi.1003632.

14. Pandey AK, Lu L, Wang X, et al. Functionally enigmatic genes: a case study of the brain ignorome. PLoS One. 2014;9(2):e88889. doi: 10.1371/journal.pone.0088889.

15. Greene CS, Krishnan A, Wong AK, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 2015;47(6):569–576. doi: 10.1038/ng.3259.

16. Eytan O, Sarig O, Sprecher E, van Steensel MAM. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14. Br J Dermatol. 2014;171(2):420–422. doi: 10.1111/bjd.12952.

17. S. Philipp A, Menter AF, Nikkels K, et al. Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients ( 6 to < 12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open-label CADMUS Jr study. Br J Dermatol. 2020 Mar 16. Online ahead of print. doi: 10.1111/bjd.19018.